Rosacea App下载

News Articles
Knowledge about the management of rosacea is expanding. The Rosacea App enables you to keep up with the latest tips and articles. These can be sent directly to your phone–be sure to check your smartphone periodically for updates.

General Rosacea Information
Learn more about your condition: What exactly is rosacea? What are the signs and symptoms of rosacea? How is rosacea treated? Did you know there may be lifestyle activities you should avoid? Different foods and drinks can be triggers? This app also provides you with helpful advice on important information to share with your healthcare provider.

Trigger Tracker
It’s important to know what your triggers are so that you can take steps to help lessen the frequency and severity of future flare ups. This tool allows you to track your flare ups and potential cause(s).

Substitution Finder
You may be able to avoid a trigger by substituting something else in its place. The Substitution Finder provides some suggestions to consider.

Weather Tracker
The Weather Tracker tool provides you with weather information and ranks the severity of the current conditions. This helps you determine whether or not the weather conditions may cause a flare up and can help guide your decision about what steps to take to help reduce the effects of these conditions.

Assessment Tool
Completing the assessment tool provides valuable information to discuss with your healthcare provider about your condition. The results are saved within the application or you can e-mail them to yourself.

Finacea
Finacea is approved for the treatment of the bumps, pimples and associated redness of mild to moderate rosacea. You can learn all about Finacea and see patient results in The Rosacea App and can take advantage of a $10 instant savings offer.

FINACEA INDICATION & USAGE
FINACEA is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated.

IMPORTANT SAFETY INFORMATION
FINACEA is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use. FINACEA is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation. In clinical trials, sensations of burning/stinging/tingling occurred in 29%% of patients, and itching in 11%%, regardless of the relationship to therapy. Post-marketing safety - Skin: facial burning and irritation; Eyes: iridocyclitis on accidental exposure to the eye. There have been isolated reports of hypopigmentation after use of azelaic acid. Since azelaic acid has not been well studied in patients with a dark complexion, these patients should be monitored for early signs of hypopigmentation.

Other than FINACEA, Intendis, Inc. (part of the Bayer group) does not promote or endorse any products or recommendations made by third parties. All products and brand names listed are the property and responsibility of their respective trademark and copyright holders.
Please see full prescribing information for FINACEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-888-INFO-FDA.

Note: This application is not intended to offer or replace professional medical advice. Please speak to your healthcare provider if you have any health concerns or questions.

FIN-28-0002-11a